Takeda Pharmaceutical Company Limited (TAK) reported a 40.0% decrease in net profit to owners of the company for the first half, with earnings per share dropping to 70.45 yen. Core operating profit was down 11.2%, and revenue for the six-month period ended September 30, 2025, decreased by 6.9% to 2.22 trillion yen. For the fiscal year ending March 31, 2026, Takeda expects basic earnings per share of 97.14 yen and revenue of 4.5 trillion yen.

For more earnings news and updates, visit rttnews.com.

Read more at NASDAQ: Takeda Pharma H1 Net Profit Declines; Revenue Down 6.9%